EFFECTS OF Β-ADRENOBLOCKERS ON MYOCARDIAL REMODELING, IMMUNO-INFLAMMATORY REACTIONS AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE

EFFECTS OF Β-ADRENOBLOCKERS ON MYOCARDIAL REMODELING, IMMUNO-INFLAMMATORY REACTIONS AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE

Show other versions (1)

<p><strong>Aim.</strong> To assess the effect of β-adrenoblockers (BAB) on myocardial remodeling, immuno-inflammatory reactions and endothelial dysfunction in patients with ischemic heart disease and chronic heart failure (CHF).</p><p><strong>Material and methods....

Full description

Bibliographic Details
Main Authors:	A. N. Zakirova, N. E. Zakirova, I. M. Karamova, N. Kh. Khafizov, O. V. Rasskazova
Format:	Article
Language:	English
Published:	Столичная издательская компания 2015-12-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	хроническая сердечная недостаточность карведилол ремоделирование миокарда иммуновоспалительные реакции дисфункция эндотелия
Online Access:	http://www.rpcardio.ru/jour/article/view/495

Similar Items

THE ROLE OF IMMUNE INFLAMMATORY REACTIONS AND ENDOTHELIAL DYSFUNCTION IN MYOCARDIAL REMODELING AND PROGRESSION OF ISCHEMIC HEART DISEASE
by: N. E. Zakirova, et al.
Published: (2015-09-01)

Relation of the heart remodeling and endothelial dysfunction in chronic heart failure patients
by: Ch. A. Abdullaeva, et al.
Published: (2016-02-01)

Carvedilol therapy effects on structural and electric remodeling in chronic heart failure
by: E. V. Minakov, et al.
Published: (2008-02-01)

The role of cardiomyocyte apoptosis in mechanisms of ischemic myocardial remodeling
by: A. P. Khlapov, et al.
Published: (2008-09-01)

Pathology of the peripheral circulation in chronic heart failure
by: A. T. Teplyakov, et al.
Published: (2017-04-01)

IMMUNO-INFLAMATORY RESPONSE IN ISCHEMIC HEART DISEASE
by: N. E. Zakirova, et al.
Published: (2015-12-01)

Features of cardiovascular remodeling, the level of neurohumoral factors depending on the degree of chronic heart failure and kidney dysfunction
by: U. K. Kamilova, et al.
Published: (2019-06-01)

Influence of endothelial NO synthase gene polymorphisms on development and prognosis of chronic heart failure
by: N. F. Yakovleva, et al.
Published: (2008-10-01)

Thrombotic event prevention in patients with post-infarction chronic heart failure, as а part of complex therapy including various classes of beta -adrenoblockers
by: Yu. V. Larina, et al.
Published: (2008-12-01)

IMMUNO-INFLAMATORY RESPONSES IN ACUTE CORONARY SYNDROME
by: R. G. Oganov, et al.
Published: (2015-12-01)

Nebivolol effects on myocardial remodelling, inflammation markers and endothelial dysfunction in chronic heart failure patients with or without Type 2 diabetes mellitus
by: Yu. N. Belenkov, et al.
Published: (2011-02-01)

Target organs in patients with post-infarction chronic heart failure: dynamics during complex therapy including beta-adrenoblockers
by: I. P. Rubesh, et al.
Published: (2008-08-01)

Long-term carvedilol therapy effects on left ventricular remodeling and glycemia in patients with chronic heart failure and Type 2 diabetes mellitus
by: R. R. Samedov, et al.
Published: (2008-02-01)

Differential beta-adrenoblocker therapy in chronic heart failure
by: S. N. Tereshchenko, et al.
Published: (1970-01-01)

Left ventricular structure and function in chronic renal disease
by: V. V. Skibitsky, et al.
Published: (2009-12-01)

N-terminal propeptide of type III procollagen for predicting diastolic dysfunction in patients with myocardial infarction and preserved ejection fraction
by: A. V. Osokina, et al.
Published: (2021-02-01)

Beta-adrenoblocker in heart failure: bisoprolol role
by: Yu. V. Lukina, et al.
Published: (1970-01-01)

Carvedilol and bisoprolol effectiveness in patients with myocardial infarction and heart failure
by: A. I. Chesnikova, et al.
Published: (2008-06-01)

RATIONAL CHOICE OF Β-ADRENOBLOCKERS IN CHRONIC HEART FAILURE THERAPY
by: M. L. Maximov
Published: (2015-12-01)

Differential approach in selecting beta-adrenoblocker therapy for patients with chronic heart failure and anaemia
by: T. M. Uskach, et al.
Published: (2012-04-01)

CLINICAL EFFICACY OF LOOP DIURETIC TORASEMIDE IN TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE. RESULTS OF KAZAKHSTAN MULTICENTER STUDY "POET"
by: S. F. Berkinbaev, et al.
Published: (2015-09-01)

Renal function in patients with anemia and severe chronic heart failure: effects of iron medications
by: M. A. Efremovtseva, et al.
Published: (2008-08-01)

The role of the cardiac lymphatic system in the development and progression of heart failure and novel therapeutic approaches for its management in post-infarction cardiac remodeling
by: Yu. S. Korneva, et al.
Published: (2020-07-01)

EFFECT OF SIMVASTATIN THERAPY ON INDICATORS OF TRANSMITRAL BLOOD FLOW IN PATIENTS WITH DIASTOLIC HEART FAILURE
by: T. V. Pinchuk, et al.
Published: (2015-09-01)

MYOCARDIAL REMODELING IN ISCHEMIC HEART DISEASE
by: A. N. Zakirova, et al.
Published: (2016-01-01)

Physiological aspects of myocardial function improving during mechanical circulatory support
by: D. V. Shumakov, et al.
Published: (2019-12-01)

Relationship between gut microbiota and markers of myocardial fibrosis in with chronic heart failure with preserved ejection fraction
by: A. N. Kaburova, et al.
Published: (2021-07-01)

Clinical efficacy of nebivolol and metoprolol in complex treatment of patients with coronary heart disease and II-III functional class chronic heart failure
by: A. G. Evdokimova, et al.
Published: (2005-04-01)

ENDOTHELIAL ADHESIVE FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE COMPLICATED BY CHRONIC HEART FAILURE AND ATRIAL FIBRILLATION
by: A. N. Zakirova, et al.
Published: (2015-09-01)

Development of Right Ventricular Dysfunction in Acute Myocardial Infarction and Chronic Heart Failure
by: L. I. Sergeyeva, et al.
Published: (2007-04-01)

Fosinopril – a drug of choice in chronic heart failure prevention and treatment
by: N. Yu. Khosyainova, et al.
Published: (2006-08-01)

Hypertensive encephalopathy, heart remodeling, and chronic heart failure
by: L. A. Geraskina, et al.
Published: (2006-06-01)

Rational pharmacotherapy of chronic heart failure with increased endothelin-1 activity: beta-adrenoblocker nebivolol place
by: L. I. Olbinskaya, et al.
Published: (2007-02-01)

Metabolic disturbances and endothelial function in elderly patients with systolic and diastolic chronic heart failure
by: I. A. Sukmanova, et al.
Published: (2009-10-01)

COMPARISON OF LOSARTAN AND LISINOPRIL EFFECTIVENESS FOR GLOMERULAR AND TUBULAR MARKERS OF RENAL DYSFUNCTION IN CHRONIC HEART FAILURE
by: U. K. Kamilova, et al.
Published: (2015-04-01)

Effects of spironolactone and eplerenone on left ventricular diastolic function and neurohumoral factors in patients with heart failure
by: N. A. Nuritdinov, et al.
Published: (2020-12-01)

CARDIORENAL RELATIONS AND QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE IN LONG TERM THERAPY WITH CARVEDILOL AND BISOPROLOL
by: M. A. Statsenko, et al.
Published: (2015-12-01)

Modern views on β-adrenoblocker therapy in elderly patients with chronic heart failure
by: E. V. Privalova
Published: (2007-06-01)

EFFECT OF MITRAL REGURGITATION ON CHRONIC HEART FAILURE COURSE AND STRUCTURE-FUNCTIONAL HEART STATE
by: V. N. Larina, et al.
Published: (2016-01-01)

Beta-adrenoblocker therapy in patients with severe chronic heart failure
by: I. I. Sinitsyna, et al.
Published: (2007-02-01)